Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 61414-16-2 | MDL No. : | MFCD04116314 |
Formula : | C24H15N3O6 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | MSFXUHUYNSYIDR-UHFFFAOYSA-N |
M.W : | 441.39 | Pubchem ID : | 5014714 |
Synonyms : |
|
Num. heavy atoms : | 33 |
Num. arom. heavy atoms : | 24 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 6 |
Num. H-bond acceptors : | 9.0 |
Num. H-bond donors : | 3.0 |
Molar Refractivity : | 117.01 |
TPSA : | 150.57 Ų |
GI absorption : | Low |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.48 cm/s |
Log Po/w (iLOGP) : | 2.52 |
Log Po/w (XLOGP3) : | 3.54 |
Log Po/w (WLOGP) : | 3.97 |
Log Po/w (MLOGP) : | 2.26 |
Log Po/w (SILICOS-IT) : | 3.25 |
Consensus Log Po/w : | 3.11 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 1.0 |
Egan : | 1.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.11 |
Log S (ESOL) : | -4.95 |
Solubility : | 0.00496 mg/ml ; 0.0000112 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -6.39 |
Solubility : | 0.000181 mg/ml ; 0.000000411 mol/l |
Class : | Poorly soluble |
Log S (SILICOS-IT) : | -6.84 |
Solubility : | 0.0000644 mg/ml ; 0.000000146 mol/l |
Class : | Poorly soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 2.0 |
Synthetic accessibility : | 2.51 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60% | Stage #1: With sulfuric acid In acetic acid for 0.0833333 h; Stage #2: With chromium(VI) oxide In acetic acid at 50℃; |
Compound A (1.0 g, 2.8 mM), acetic acid (24.85 mL) and H2SO4 (1.58 mL) were taken in a 100 mL flask and stirred for 5 min. After heating the mixture to 50 °C, chromium trioxide (2.58 g) dissolved in a mixture of acetic acid (5 mL) and H2SO4 (5 mL) was added slowly. The dark brown slurry was stirred overnight followed by the filtration of the reaction mixture. The residue was collected and re-dissolved in 2 N NaOH and filtered to remove any insoluble impurity. The final product was obtained by acidifying the solution with 6 N HCl which gave B (H3TATB) as a white precipitate in 60percent yield. 1H NMR (400 MHz, DMSO‑d6) δ = 8.80 ppm (d, J = 8.5 Hz, 6H), 8.18 (d, J = 8.5 Hz, 6H); MS (ESI)(m/z):[M-H]- calc. for C24H14N3O6, 440.0800, found 440.0100. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60% | Compound A (1.0?g, 2.8?mM), acetic acid (24.85?mL) and H2SO4 (1.58?mL) were taken in a 100?mL flask and stirred for 5?min. After heating the mixture to 50?C, chromium trioxide (2.58?g) dissolved in a mixture of acetic acid (5 mL) and H2SO4 (5 mL) was added slowly. The dark brown slurry was stirred overnight followed by the filtration of the reaction mixture. The residue was collected and re-dissolved in 2?N NaOH and filtered to remove any insoluble impurity. The final product was obtained by acidifying the solution with 6?N HCl which gave B (H3TATB) as a white precipitate in 60% yield. 1H NMR (400?MHz, DMSO-d6) delta = 8.80?ppm (d, J?=?8.5?Hz, 6H), 8.18 (d, J?=?8.5?Hz, 6H); MS (ESI)(m/z):[M-H]- calc. for C24H14N3O6, 440.0800, found 440.0100. | |
With chromium(VI) oxide; sulfuric acid; acetic anhydride; acetic acid; at 50℃; | A 500 mL three-necked flask was charged with C (2.78 g) dissolved in acetic acid (70 mL). Then add of H2S04 (4.4 mL). Chromium oxide (7.2 g) was dissolved in acetic anhydride (4.8 mL) with stirring, then carefully added into the solution slowly, using a cold water-ice bath to keeping the temperature below 50 C. The resulting black-brown slurry was stirred overnight. The reaction mixture was poured into 300 mL cold water, stirred (1 hour) to mix, then filtered. The solid was washed with water to remove the chromium acid. The resultant white solid was dissolved in 200 mL 2N NaOH solution. After the unreacted starting material was removed by filtration, the solution was acidified with 10% HC1 solution to give white crude product precipitate (until pH<3). The crude product was filtered and dried. Recrystallization from DMF gave pure product as a white solid. NMR (300 MHz, DMSO): delta = 8.20 (d, 6 H), 8.85 (d, 6 H), 13.35 (s, 3 H) ppm. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
47.1% | With cetyltrimethylammonim bromide; In methanol; at 105℃; for 0.75h;Sealed tube; | Use of europium nitrate and terbium nitrate and 2, 4, 6-tri (4-carboxy phenyl) - 1, 3, 5-triazine, through solvent heat method to synthetic micro-nano scale rare earth organic framework material, its specific synthetic route is as follows: The 0.0615mmol of europium nitrate and 0.0885mmol terbium nitrate of (mol ratio Eu 3+: Tb 3+ = 41:59), 0.075mmol of the 2, 4, 6-tri (4-carboxy phenyl) - 1, 3, 5-triazine and 0.9mmol of cetyl trimethyl ammonium bromide dissolved in 36 ml of N, N-dimethyl acetamide (DMA) in, addition of 7.2 ml methanol and 1.8 ml of deionized water are added to a wherein prepared mixed solution, and then the mixed solution is put into a sealed glass bottle, the 105 C violent stirring 45 minutes, the centrifugation, washing, to obtain micro-nano scale rare earth organic framework material [Eu 0.41 Tb 0.59 L (DMA) (H 2 O)] · (DMA) 3 (Figure 1), the size of 1000 nm the left and right, the yield is 47.1%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In ethanol; at 115℃; for 24h; | The reaction mixture containing EuCl3.6H2O (0.021 mmol, 8 mg), 4,4?,4?-s-triazine-2,4,6-triyl-tribenzoic acid, (TTB) (0.043 mmol, 19 mg), N,N?-diethylformamide (DEF) (2 mL), and EtOH (3 mL) was placed in a 20 mL scintillation vial and was heated to 115 C. for 1 day at a rate of 1.5 C./min and cooled to room temperature at a cooling rate of 1 C./min. Plate-like crystalline material was obtained. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In ethanol; at 115℃; for 72h; | The reaction mixture containing In(NO3)3.5H2O (0.021 mmol, 8.5 mg), 4,4?,4?-s-triazine-2,4,6-triyl-tribenzoic acid (TTB) (0.021 mmol, 9.5 mg), oxalic acid (OA) (0.065 mmol, 5.85 mg), and N,N?-dimethylformamide (DMF) (2 mL), EtOH (3.25 mL) was placed in a 20 mL scintillation vial and was heated to 115 C. for 3 days at a rate of 1.5 C./min and cooled to room temperature at a cooling rate of 1 C./min. On the basis of the purity of the organic linker, a co-precipitation of a secondary crystalline phase may be noted, under these conditions; for the photoluminescence measurements reported herein, a pure sample of 3 was studied. Crystalline material with polyhedral morphology was obtained |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With 3,5-Pyridinedicarboxylic acid; nitric acid; at 110℃; for 72h;High pressure; | Compound 2 was synthesized exactly like 1 except using H3TATB instead of H3BTB. In detail,3,5-PDC (0.01 g, 0.06 mmol) and H3TATB (0.01 g, 0.23 mmol) were dissolved in a solution containingDMF (4.0 mL, 52 mmol), H2O (1.0 mL, 0.055 mol) and 5 drops HNO3. Then YbCl3·6H2O(0.03 g, 0.08 mmol) was added into the primary solution and dissolved while stirring at roomtemperature. The nal solution was transferred to a glass container and sealed. The samplewas heated to 110 C with a rate of 0.5 C min-1 and kept at this temperature for 72 h and thencooled to room temperature over 48 h. White cubic crystals were obtained. FTIR (KBr, cm-1):3048, 2923, 2852, 1677, 1548, 1503, 1420, 1400, 1193, 1100, 883, 1089, 819, 777, 700, 565, 500,399. Anal. Calcd (Found) for C99H67N13O31Yb4: C 45.27 (44.32), H 2.57 (2.76), N 6.93 (7.32). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
at 130℃; for 48h; | At room temperature, 0.1 mmol 4,4',4'-(1,3,5-triazine)-2,4,6-tribenzoic acid, 0.075 mmolIndium chloride and 0.075 mmol tetraethylammonium bromide,It was added to a 10 ml solution of N,N'-diethylformamide and gradually warmed to 130C. After 48 hours of reaction, it was cooled to room temperature, filtered and washed with N,N'-diethylformamide and ethanol, respectively. After washing with dichloromethane and vacuum drying, a porous indium-organic framework material A was obtained. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
at 100℃; for 24h; | under room temperature, 0.1mmol of 4, 4?, 4? (1, 3, 5-triazine)-2, 4, 6-tribenzoic acid, 0.075mmol of indium nitrate hydrate and 0.075mmol of tetraethyl ammonium chloride, added into 10ml of N, N'-diethyl formamide solution, gradually warms up at 100C, reacts for 24 hours, then returns at room temperature and is filtered, washed with N, N'-diethyl formamide, ethanol, and dichloromethane respectively, Vacuum drying, and then obtained Porous Indium-Organic Frame Material A. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
at 130℃; for 48h; | At room temperature, 0.1 mmol of 4,4',4'-(1,3,5-triazine)-2,4,6-tribenzoic acid, 0.075 mmolIndium chloride and 0.075 mmol of tetraethylammonium chloride,It was added to a 10 ml solution of N,N'-diethylformamide and gradually warmed to 130C. After 48 hours of reaction, it was cooled to room temperature, filtered and washed with N,N'-diethylformamide and ethanol, respectively. Dichloromethane washing and vacuum drying to obtain porous indium-organic framework material A |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
40% | Ca(NO3)2.4(H2O) (0.060g, 0.25mM) and H3TATB (0.073g, 1.65mM) were dissolved in 1mL of DMA and stirred for 15min. The clear solution was transferred to a glass tube of 10mm, frozen in liq. N2 and sealed under vacuum. The tube was placed at 110C for 72 h. Colorless rod shaped crystals of 1 were formed in 40% yield. Anal Calc. (Found) for [Ca6(TATB)4(H2O)(DMA)4] with six DMA molecules: C 56.66 (55.91); H 4.89 (5.03); N 10.69 (10.33%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With strontium (III) chloride hexahydrate; nitric acid; o-fluoro-benzoic acid; In water; at 105℃; for 48h;High pressure; | A mixture of SrCl26H2O (27 mg, 0.1 mmol,), organic linker H3TATB (24 mg, 0.05 mmol), were dissolved in a mixture of 12mL DMF (N,N-dimethylformamide)/1.8mL H2O, to which 2-fluorobenzoic acid (346.2 mg, 2.47 mmol) and 210 mL HNO3 (69%, aq.) were added in a 15mL scintillation vial and then, the mixture was stirred until homogeneity. Subsequently, the vial was heated to 105 C for 2 days in a preheated oven. The resultant colorless hexagonal flakeshaped crystals were washed with DMF three times to afford 2. Elemental analysis calcd (%) for 2 (C54H71N9O26Sr4): C,40.22; H, 4.44; N, 7.82; found: C, 40.11; H, 4.39; N, 7.66. IR for 2: 3392 m, 1923 m, 1578 s, 1501 s, 1344 s, 1170 m, 1015 m,886 m, 760 s, 721m cm1. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
53% | With sodium hydroxide; In water; at 165℃; for 120h;Autoclave; High pressure; | A mixture of Tb(NO3)3·6H2O (10.0 mg, 0.022 mmol) and H3L (7 mg, 0.014 mmol) was putted in a 20.0 mL Teflon-lined autoclave with 3 mL H2O, following adding NaOH aqueous solution (0.01 M, 30 muL). The mixture was stirred at indoor temperature for 20 minutes, then putted in a constant heating oven at 165C for 5 days. The yellow block-shaped crystals can be successfully achieved and collected after slowly cooling to room temperature. The achieved large single crystal can be used for the single-crystal X-ray measurement. The final yield is about 53% based on H3L. Anal. calcd for C24H21N6O9Tb: C 41.4, H 3.0, N 12.1%; and found: C 41.5 H 2.9, N 12.1%. Selected FT-IR spectra: 3420 (br), 2367 (m), 1623 (s), 1580 (s), 1520 (s), 1415 (s), 1129 (s), 997 (s), 893 (s), 757 (s), 679 (s), 514 (s) (Fig. S5). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
76% | With barium(II) nitrate; water; at 100℃; for 120h; | A mixture of 0.052 g (0.2 mmol) ofBa(NO3)2 and 0.087 g (0.2 mmol) of H3TATB were weighed in a clean glass vial and dissolved in 10 mL ofDMF. The mixture was sonicated and then kept in anoven at 100C for 120 h. Colorless crystals of I werecollected (in a yield of 76% with respect to the ligand)and washed with DMF.The activated I (Ia) was prepared by soaking thecrystalline samples of I in MeOH for three days (freshMeOH was replaced in each 12 h) and then pumpedunder high vacuum for one day at 80C. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
at 120℃; for 72h;Autoclave; High pressure; | A mixture of H3TATB (0.044 g, 0.1 mmol), Zn(NO3)26H2O(0.060 g, 0.2 mmol), bib (0.024 g, 0.1 mmol), DMF (11 ml) andwater (4 ml) was placed in a Teflon reactor (20 ml) and heatedat 120 C for 3 d. After cooling to room temperature at a rateof 10 C h1, the resulting crystals were collected from themixture and dried in air with a yield of about 65% (based onZn). Selected IR peaks (cm1): 3487 (m), 3123 (m), 2926 (w),2862 (w), 1669 (m), 1613 (m), 1581 (m), 1510 (m), 1233 (w),883 (s), 820 (s), 776 (s), 696 (s). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
68% | With formic acid In 1,4-dioxane at 150℃; for 72h; Autoclave; | Preparation and characterization for coordination polymers [Yb1.5(TAPB)1.5(DMF)]*9DMF}n (1) and[Yb(TCBPA)*DMF]n (2) For complex 1, we mixed Yb(NO3)26H2O of 0.046 g and 0.05 mmol, H3TAPB which is 0.020 g and 0.03 mmol, 2.5mL DMF, 1,4-dioxane of 0.5mL as well as HCOOH of three drops to form the mixture, and sealed the obtained mixture in stainless steel reactor lined with Teflon of 25 mL and heated it for three days at 150 C under the pressure of autogenous. After cooling it to the ambient temperature, we acquired colorless crystals with block-shape suitable for the analysis of X-ray diffraction. The yield was 68% for 1 (onthe basis of H3TAPB ligand). Anal. Calcd for 1 (Yb1.5C93N14.5O19H110.5): C, 56.44; H, 5.63; N, 10.26%; found: C 56.16, H 5.82, N 10.21%. IR (cm1): 3131(m),2357(w), 1624(m), 1523(m), 1401(m), 1303(s), 1256(w), 1138(m), 1058(s), 956(m), 823(m), 731(m), 652(w),529(w), 463(w). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: terbium(III) nitrate hexahydrate; 4,4′,4′′-(1,3,5-triazine-2,4,6-triyl) tribenzoic acid; N,N-dimethyl-formamide In water Heating; Stage #2: With sodium hydroxide In water at 160℃; for 48.5h; | 2.2. Syntheses of lanthanide-organic complexes General procedure: A series of rare earth organic complexes Ln-TCTZ(DMF)·2H2O(Ln = Tb, Eu, Tb0.99Eu0.01) were synthesized by solvothermal method.All the lanthanide-organic complexes were prepared in a similarapproach. This series of compounds are abbreviated below as Ln-TCTZ.The organic ligand 2,4,6-tris(4-carboxyphenyl)-1,3,5-triazine wasdissolved in a solvent, which was mixed with N,N-dimethylformamide(DMF) and deionized water in a volume ratio of 4:1(20 ml: 5 ml). Thesolution was heated in a water bath with a magnetic stirrer and stirreduntil the ligand was sufficiently dissolved in the solvent. [Ln(NO3)3]·6H2O solution was added into the ligand solution, with mild heatingand stirring until the mixture was clear. Dilute NaOH aqueous solutionwas utilized to adjust the pH value (pH = 5-6).White precipitate wasimmediately formed. After stirring for 30 min, the mixture wastransferred into one 50-mL Teflon lining and then packaged it intostainless kettle. The kettle was incubated at 160 °C for 48 h, allowed tocool to room temperature. The white powder samples were finallyobtained by filtering and drying the mixture in the kettle. The filteredclean solution was retained to develop single crystal. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: terbium(III) nitrate hexahydrate; europium(III) nitrate hexahydrate; 4,4′,4′′-(1,3,5-triazine-2,4,6-triyl) tribenzoic acid; N,N-dimethyl-formamide In water Heating; Stage #2: With sodium hydroxide In water at 160℃; for 48.5h; | 2.2. Syntheses of lanthanide-organic complexes General procedure: A series of rare earth organic complexes Ln-TCTZ(DMF)·2H2O(Ln = Tb, Eu, Tb0.99Eu0.01) were synthesized by solvothermal method.All the lanthanide-organic complexes were prepared in a similarapproach. This series of compounds are abbreviated below as Ln-TCTZ.The organic ligand 2,4,6-tris(4-carboxyphenyl)-1,3,5-triazine wasdissolved in a solvent, which was mixed with N,N-dimethylformamide(DMF) and deionized water in a volume ratio of 4:1(20 ml: 5 ml). Thesolution was heated in a water bath with a magnetic stirrer and stirreduntil the ligand was sufficiently dissolved in the solvent. [Ln(NO3)3]·6H2O solution was added into the ligand solution, with mild heatingand stirring until the mixture was clear. Dilute NaOH aqueous solutionwas utilized to adjust the pH value (pH = 5-6).White precipitate wasimmediately formed. After stirring for 30 min, the mixture wastransferred into one 50-mL Teflon lining and then packaged it intostainless kettle. The kettle was incubated at 160 °C for 48 h, allowed tocool to room temperature. The white powder samples were finallyobtained by filtering and drying the mixture in the kettle. The filteredclean solution was retained to develop single crystal. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: europium(III) nitrate hexahydrate; 4,4′,4′′-(1,3,5-triazine-2,4,6-triyl) tribenzoic acid; N,N-dimethyl-formamide In water Heating; Stage #2: With sodium hydroxide In water at 160℃; for 48.5h; | 2.2. Syntheses of lanthanide-organic complexes General procedure: A series of rare earth organic complexes Ln-TCTZ(DMF)·2H2O(Ln = Tb, Eu, Tb0.99Eu0.01) were synthesized by solvothermal method.All the lanthanide-organic complexes were prepared in a similarapproach. This series of compounds are abbreviated below as Ln-TCTZ.The organic ligand 2,4,6-tris(4-carboxyphenyl)-1,3,5-triazine wasdissolved in a solvent, which was mixed with N,N-dimethylformamide(DMF) and deionized water in a volume ratio of 4:1(20 ml: 5 ml). Thesolution was heated in a water bath with a magnetic stirrer and stirreduntil the ligand was sufficiently dissolved in the solvent. [Ln(NO3)3]·6H2O solution was added into the ligand solution, with mild heatingand stirring until the mixture was clear. Dilute NaOH aqueous solutionwas utilized to adjust the pH value (pH = 5-6).White precipitate wasimmediately formed. After stirring for 30 min, the mixture wastransferred into one 50-mL Teflon lining and then packaged it intostainless kettle. The kettle was incubated at 160 °C for 48 h, allowed tocool to room temperature. The white powder samples were finallyobtained by filtering and drying the mixture in the kettle. The filteredclean solution was retained to develop single crystal. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
76% | With barium(II) nitrate; water at 99.84℃; for 72h; | Synthesis complex I. A mixture H3TATB (0.2 mmol, 87 mg), Ba(NO3)2 (0.2 mmol, 52 mg), DMF (6 mL), and water (4 mL) was added into a clean glass vial. The solution was dealt with ultrasonic treatment and then kept at 373 K in an oven for 3 days. Colorless crystalline products of were produced, cleaned by EtOH and left in the air to make them dried. The yield of I was 76% on the basis of the H3TATB ligandused. For C36H44N7O12Ba (I) Anal. calcd., % C, 47.83 H, 4.91 N, 10.84 Found, % C, 47.51 H, 4.69 N, 10.26 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In water; N,N-dimethyl-formamide; at 120℃; for 72h; | In a mixed solvent of water and N,N-dimethylformamide (volume ratio 1:3), Combine <strong>[1258947-79-3]tris(4-imidazolylphenyl)amine</strong>, 4,4',4”-(1,3,5-triazine-2,4,6-triyl)tris-trimellitic acid and FeSO4 source in molar ratio 1:1:2 is mixed evenly and then put into the reactor. React hydrothermally at 120 C for 72h, then cool down to 100 C at 10 h-1. then drop to room temperature to crystallize for 3d. Then, the crystals obtained by cooling and crystallization are successively filtered, washed, and dried to obtain more red crystals of imidazole derivative-polyvalent aromatic carboxylate iron complex. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
51% | In tetrahydrofuran at 170℃; for 72h; Autoclave; | Synthesis of [Eu(TATB)(H2O)]n (referred to as Eu-TATB) H3TATB (0.046 g, 0.10 mmol), europium(III) nitrate hexahydrate(0.089 g, 0.20 mmol), 4 mL of H2O, and 8 mL of THF were mixed in aTeflon-lined autoclave with a volume of 25 mL, and heated at 170 C for3 days. Brown block crystals were obtained by filtration and washedseveral times with ethanol, and Yield: 51% (based on Eu(NO3)36H2Oinput). Elemental analysis calcd (%) for C24H14EuN3O7 (608.35): C47.38, H 2.30, N 6.91; found: C 47.52, H 2.19, N 6.48. IR (KBr pellet,cm2): 3421 (w), 2924 (m), 2854 (m), 1611 (m), 1536 (vs), 1506 (m),1403 (vs), 1358 (s), 1015 (m), 885 (m), 819 (m), 778 (s), 699 (m) |
Tags: 61414-16-2 synthesis path| 61414-16-2 SDS| 61414-16-2 COA| 61414-16-2 purity| 61414-16-2 application| 61414-16-2 NMR| 61414-16-2 COA| 61414-16-2 structure
[ 1088994-22-2 ]
5-Methyl-2-(pyrimidin-2-yl)benzoicacid
Similarity: 0.86
[ 42823-72-3 ]
4-Carbamimidoylbenzoic acid hydrochloride
Similarity: 0.75
[ 1172889-96-1 ]
Methyl 4-carbamimidoylbenzoate acetate
Similarity: 0.71
[ 1088994-22-2 ]
5-Methyl-2-(pyrimidin-2-yl)benzoicacid
Similarity: 0.86
[ 104866-53-7 ]
1,8-Naphthyridine-3-carboxylic acid
Similarity: 0.79
[ 14544-47-9 ]
4,4',4''-(1,3,5-Triazine-2,4,6-triyl)trianiline
Similarity: 0.69
[ 1073062-59-5 ]
2-(3,5-Dibromophenyl)-4,6-diphenyl-1,3,5-triazine
Similarity: 0.67
[ 30363-03-2 ]
2,4,6-Tris(4-bromophenyl)-1,3,5-triazine
Similarity: 0.67
[ 890148-78-4 ]
2,4,6-Tris(3-bromophenyl)-1,3,5-triazine
Similarity: 0.66
[ 203450-08-2 ]
2-(4-Fluorophenyl)-4,6-diphenyl-1,3,5-triazine
Similarity: 0.64
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :